Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck.
Chen Z, Zhang X, Li M, Wang Z, Wieand HS, Grandis JR, Shin DM.
Clin Cancer Res. 2004 Sep 1;10(17):5930-9.
PMID: 15355926
Most head-and-neck cancers that recur locally after prior full-dose conventional radiation therapy respond to Boron Neutron Capture Therapy (BNCT). These results were obtained in a Phase I/II study at the Helsinki University Hospital, Finland. The scienti
Boron Neutron Capture Therapy in the Treatment of Locally Recurred Head and Neck Cancer. Corrected Proof, 7 August 2007
Leena Kankaanranta, Tiina Seppälä, Hanna Koivunoro, Kauko Saarilahti, Timo Atula, Juhani Collan, Eero Salli, Mika Kortesniemi, Jouni
Scheper MA, Nikitakis NG, Chaisuparat R, Montaner S, Sauk JJ.
Sulindac Induces Apoptosis and Inhibits Tumor Growth in vivo in Head and Neck Squamous Cell Carcinoma.
Neoplasia. 2007 Mar;9(3):192-9.
PMID: 17401459 [PubMed - in process]
Laskawi R, Ellies M.
The role of botulinum toxin in the management of head and neck cancer patients.
Curr Opin Otolaryngol Head Neck Surg. 2007 Apr;15(2):112-6.
PMID: 17413413 [PubMed - in process]
Awada A, Ismael G.
The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck.
Curr Opin Oncol. 2007 May;19(3):177-9.
PMID: 17414633 [
"Maté consumption plays a significant and independent role in the development of upper aeodigestive tract cancers," and "Maté drinking should be considered one of the risk factors for cancer of the neck and head."
A ground-breaking Canada-wide clinical trial led by Dr. Katherine Borden, at the Institute for Research in Immunology and Cancer (IRIC) of the Universit de Montral, has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of cancer patients. Published in the journal Blood (First Edition), the study demonstrates that ribavirin suppresses the activities of the eIF4E gene in patients. This gene is dysregulated in 30 percent of cancers including breast, prostate, head and neck, colon and stomach cancer.
The beverage maté: a risk factor for cancer of the head and neck.
Goldenberg D, Golz A, Joachims HZ.
Head Neck. 2003 Jul;25(7):595-601. Review.
PMID: 12808663
DOI: 10.1002/hed.10288
Selenium and immunocompetence in patients with head and neck cancer.
Kiremidjian-Schumacher L, Roy M, Glickman R, Schneider K, Rothstein S, Cooper J, Hochster H, Kim M, Newman R.
Biol Trace Elem Res. 2000 Feb;73(2):97-111.
PMID: 11049203
DOI: 10.1385/BTER:73:2:97
Combination immunotherapy of squamous cell carcinoma of the head and neck: a phase 2 trial.
Barrera JL, Verastegui E, Meneses A, Zinser J, de la Garza J, Hadden JW.
Arch Otolaryngol Head Neck Surg. 2000 Mar;126(3):345-51.
PMID: 10722007
Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck.
Cohen EE, Halpern AB, Kasza K, Kocherginsky M, Williams R, Vokes EE.
Oral Oncol. 2009 Oct;45(10):e155-60. Epub 2009 Jul 7.
PMID: 19586795